Community Translations
Community Translations
Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer
Pertuzumab injection was granted accelerated approval by the US Food and Drug Administration last fall for use in combination with trastuzumab...
Community Translations
Dabrafenib in advanced melanoma with BRAF V600E mutation
Dabrafenib was recently approved by the US Food and Drug Administration for treatment of unresectable or metastatic melanoma with BRAF V600E...
Community Translations
Afatinib in metastatic NSCLC with mutations
In July 2013, afatinib was approved by the US Food and Drug Administration for first-line treatment of patients with metastatic non–small-cell...